Cannabinoids Fall Short Across Most Psychiatric Disorders - Summary - MDSpire

Cannabinoids Fall Short Across Most Psychiatric Disorders

"[T]he routine use of cannabinoids for the treatment of mental disorders and SUDs is rarely justified."

  • By

  • Kathryn Wighton

  • July 24, 2026

  • 4 min

Share

Original Source(s)

Cannabinoids Fall Short Across Most Psychiatric Disorders

  • by Kathryn Wighton

  • July 24, 2026

Related Content

The Cannabis Talk That Doesn't Happen

Clinicians screened just one in three older patients for drug use, and discussed cannabis with fewer still—leaving women and minoritized groups out most.

Top 10 States Offering Large Physician Loan Repayment Programs

These states offer physician loan repayment and student loan forgiveness programs through state-supported workforce initiatives.

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.